Welzenbach Mark Joseph 4

4 · HANOVER INSURANCE GROUP, INC. · Filed Feb 8, 2022

Form 4

Period: 2022-02-04

Senior Vice President

Transactions

Exercise/Conversion
Common Stock Option (right to buy)
2022-02-04−10,377→ 0 total
Exercise: $104.11Exp: 2028-02-27→ Common Stock (10,377 underlying)
Exercise/Conversion
Common Stock
2022-02-04$104.11/sh+10,377$1,080,349→ 30,419.077 total
Sale
Common Stock
2022-02-04$138.50/sh−10,377$1,437,215→ 20,042.077 total
Exercise/Conversion
Common Stock
2022-02-04$117.22/sh+4,686$549,293→ 24,728.077 total
Sale
Common Stock
2022-02-04$140.42/sh−4,686$658,030→ 20,042.077 total
Exercise/Conversion
Common Stock Option (right to buy)
2022-02-04−4,686→ 2,343 total
Exercise: $117.22Exp: 2029-03-05→ Common Stock (4,686 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $140.11 to $140.55. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
[F2]The option, representing the right to purchase a total of 15,566 shares, vested 1/3 on each of 2/27/19, 2/27/20 and 2/27/21.
[F3]The option, representing the right to purchase a total of 7,029 shares, vested 1/3 on each of 3/05/20 and 3/05/21 and the remaining 1/3 shall vest on 3/05/22.

Documents

1 file